DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 7-8, 2007, Pages 1523-1538

  Ivascu, Claudia ^a   Wasserkort, Reinhold ^a   Lesche, Ralf ^a   Dong, Jun ^b   Stein, Harald ^c   Thiel, Andreas ^b   Eckhardt, Florian ^a  

^a EPIGENOMICS AG   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Differential methylation; DNA methylation; Hematopoiesis; Lymphoma; Transcription factors

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF;

ADULT; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHOCYTE; LYMPHOMA CELL LINE; MALE; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL LINEAGE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIESIS; HUMANS; LYMPH NODES; LYMPHOCYTES; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, T-CELL; TRANSCRIPTION FACTORS;

EID: 34447093157     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.02.006     Document Type: Article

References (58)

1. Agrelo R., Setien F., Espada J., Artiga M.J., Rodriguez M., Perez-Rosado A., et al. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. Journal of Clinical Oncology 23 (2005) 3940-3947
2. Amaravadi L., and Klemsz M.J. DNA methylation and chromatin structure regulate PU1 expression. DNA and Cell Biology 18 (1999) 875-884
3. Anderson M.K. At the crossroads: Diverse roles of early thymocyte transcriptional regulators. Immunological Reviews 209 (2006) 191-211
4. Berlin, K., Ballhause, M., & Cardon, K. (2005). PCT/WO/2005/038051.
5. Bird A. DNA methylation patterns and epigenetic memory. Genes & Development 16 (2002) 6-21
6. Bonifer C., Lefevre P., and Tagoh H. The regulation of chromatin and DNA-methylation patterns in blood cell development. Current Topics in Microbiology and Immunology 310 (2006) 1-12
7. + T cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter. European Journal of Immunology 35 (2005) 1408-1417
8. Cousins D.J., Lee T.H., and Staynov P.A. Cytokine coexpression during human Th1/Th2 cell differentiation: Direct evidence for coordinated expression of Th2 cytokines. The Journal of Immunology 169 (2002) 2498-2506
9. Dorfman D.M., Hwang E.S., Shahsafaei A., and Glimcher L.H. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. American Journal of Clinical Pathology 122 (2004) 292-297
10. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., Burger M., et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genetics 38 (2006) 1378-1385
11. Esteller M. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21 (2002) 5427-5440
12. Esteller M. Profiling aberrant DNA methylation in hematologic neoplasms: A view from the tip of the iceberg. Clinical Immunology 109 (2003) 80-88
13. Esteller M. Aberrant DNA methylation as a cancer-inducing mechanism. Annual Review of Pharmacology and Toxicology 45 (2005) 629-656
14. Esteller M., Gaidano G., Goodman S.N., Zagonel V., Capello D., Botto B., et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. Journal of the National Cancer Institute 94 (2002) 26-32
15. Estrov Z., Talpaz M., Ku S., Harris D., Van Q., Beran M., et al. Z-138: A new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia. Leukemia Research 22 (1998) 341-353
16. Futscher B.W., Oshiro M.M., Wozniak R.J., Holtan N., Hanigan C.L., Duan H., et al. Role for DNA methylation in the control of cell type specific maspin expression. Nature Genetics 31 (2002) 175-179
17. Glimcher L.H., and Murphy K.M. Lineage commitment in the immune system: The T helper lymphocyte grows up. Genes & Development 14 (2000) 1693-1711
18. Glimcher L.H., and Singh H. Transcription factors in lymphocyte development-T and B cells get together. Cell 96 (1999) 13-23
19. Gomes I., Sharma T.T., Edassery S., Fulton N., Mar B.G., and Westbrook C.A. Novel transcription factors in human CD34 antigen-positive hematopoietic cells. Blood 100 (2002) 107-119
20. Guo J., Burger M., Nimmrich I., Maier S., Becker E., Genc B., et al. Differential DNA methylation of gene promoters in small B-cell lymphomas. American Journal of Clinical Pathology 124 (2005) 430-439
21. Guo M., Akiyama Y., House M.G., Hooker C.M., Heath E., Gabrielson E., et al. Hypermethylation of the GATA genes in lung cancer. Clinical Cancer Research 10 (2004) 7917-7924
22. Hatton R.D., and Weaver C.T. Immunology. T-bet or not T-bet. Science 302 (2003) 993-994
23. He X., He X., Dave V.P., Zhang Y., Hua X., Nicolas E., et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433 (2005) 826-833
24. He X., and Kappes D.J. CD4/CD8 lineage commitment: Light at the end of the tunnel?. Current Opinion in Immunology 18 (2006) 135-142
25. Hernandez-Hoyos G., Anderson M.K., Wang C., Rothenberg E.V., and Alberola-Ila J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19 (2003) 83-94
26. + T cells for effective immunotherapy. Current Opinion in Immunology 18 (2006) 363-370
27. Ho I.C., and Glimcher L.H. Transcription: Tantalizing times for T cells. Cell 109 (2002) S109-S120
28. Ho I.C., Lo D., and Glimcher L.H. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. Journal of Experimental Medicine 188 (1998) 1859-1866
29. Hromas R., Orazi A., Neiman R.S., Maki R., Van Beveran C., Moore J., et al. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU 1. Blood 82 (1993) 2998-3004
30. + T cell fate coupled by T-bet and eomesodermin. Nature Immunology 6 (2005) 1236-1244
31. Kimmig S., Przybylski G.K., Schmidt C.A., Laurisch K., Mowes B., Radbruch A., et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. Journal of Experimental Medicine 195 (2002) 789-794
32. Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., and Maki R.A. The macrophage and B cell-specific transcription factor PU. 1 is related to the ets Oncogene. Cell 61 (1990) 113-124
33. Korz C., Pscherer A., Benner A., Mertens D., Schaffner C., Leupolt E., et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 99 (2002) 4554-4561
34. Kurata H., Lee H.J., McClanahan T., Coffman R.L., O'Garra A., and Arai N. Friend of GATA is expressed in naive Th cells and functions as a repressor of GATA-3-mediated Th2 cell development. Journal of Immunology 168 (2002) 4538-4545
35. Lee D.U., Agarwal S., and Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16 (2002) 649-660
36. Lewin J., Schmitt A.O., Adorjan P., Hildmann T., and Piepenbrock C. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics 20 (2004) 3005-3012
37. Loots G.G., Locksley R.M., Blankespoor C.M., Wang Z.E., Miller W., Rubin E.M., et al. Identification of a coordinate regulator of interleukins 4,13 and 5 by cross-species sequence comparisons. Science 288 (2000) 136-140
38. Marafioti T., Ascani S., Pulford K., Sabattini E., Piccioli M., Jones M., et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. American Journal of Pathology 162 (2003) 861-871
39. Muller P.Y., Janovjak H., Miserez A.R., and Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32 (2002) 1372-1374, 1376, 1378-1379
40. Murayama A., Sakura K., Nakama M., Yasuzawa-Tanaka K., Fujita E., Tateishi Y., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. The EMBO Journal 25 (2006) 1081-1092
41. Orkin S.H. Diversification of haematopoietic stem cells to specific lineages. Nature Reviews Genetics 1 (2000) 57-64
42. Palmisano W.A., Crume K.P., Grimes M.J., Winters S.A., Toyota M., Esteller M., et al. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. Cancer Research 63 (2003) 4620-4625
43. + T cell function by the transcription factor Eomesodermin. Science 302 (2003) 1041-1043
44. Rakyan V.K., Hildmann T., Novik K.L., Lewin J., Tost J., Cox A.V., et al. DNA methylation profiling of the human major histocompatibility complex: A pilot study for the human epigenome project. PLoS Biology 2 (2004) e405
45. Rasmussen T., Knudsen L.M., Dahl I.M., and Johnsen H.E. C-MAF oncogene dysregulation in multiple myeloma: Frequency and biological relevance. Leukemia & Lymphoma 44 (2003) 1761-1766
46. Reiner S.L. Epigenetic control in the immune response. Human Molecular Genetics 14 (2005) R41-R46
47. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
48. Rosenbauer F., Owens B.M., Yu L., Tumang J.R., Steidl U., Kutok J.L., et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU. 1. Nature Genetics 38 (2006) 27-37
49. Rothenberg E.V., and Taghon T. Molecular genetics of T cell development. Annual Review of Immunology 23 (2005) 601-649
50. Singh H., and Pongubala J.M. Gene regulatory networks and the determination of lymphoid cell fates. Current Opinion in Immunology 18 (2006) 116-120
51. Smiraglia D.J., and Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 21 (2002) 5414-5426
52. Song F., Smith J.F., Kimura M.T., Morrow A.D., Matsuyama T., Nagase H., et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 3336-3341
53. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
54. Tenen D.G., Hromas R., Licht J.D., and Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90 (1997) 489-519
55. Tsang A.P., Fujiwara Y., Hom D.B., and Orkin S.H. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes & Development 12 (1998) 1176-1188
56. Willinger T., Freeman T., Herbert M., Hasegawa H., McMichael A.J., and Callan M.F. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. Journal of Immunology 176 (2006) 1439-1446
57. Woolfe A., Goodson M., Goode D.K., Snell P., McEwen G.K., Vavouri T., et al. Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biology 3 (2005) e7
58. Wu L. T lineage progenitors: The earliest steps en route to T lymphocytes. Current Opinion in Immunology 18 (2006) 121-126